Stay updated on DTX301 Clinical Trial in Late-Onset OTC Deficiency
Sign up to get notified when there's something new on the DTX301 Clinical Trial in Late-Onset OTC Deficiency page.
Latest updates to the DTX301 Clinical Trial in Late-Onset OTC Deficiency page
- Check2 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed from the page.SummaryDifference0.1%
- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check31 days agoChange DetectedLocations sections were updated: new sites across the US, Canada, Spain, and the UK were added (Colorado, Massachusetts, New York, Ohio, Alberta, A Coruna, Vizcaya, London City) and the corresponding location entries were removed. The page revision label was updated to v3.3.3.SummaryDifference0.9%
- Check52 days agoChange DetectedFooter revision tag updated from v3.3.1 to v3.3.2, indicating a minor site update with no changes to study details or core content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check59 days agoChange DetectedThe page now displays Revision: v3.3.1, replacing the previous Revision: v3.2.0.SummaryDifference0.1%
- Check66 days agoChange DetectedDeleted the government funding status notice from the page. Core study details, eligibility criteria, locations, and outcome measures remain unchanged.SummaryDifference0.4%
- Check81 days agoChange DetectedNo significant changes to the study details were detected; the page content remains focused on safety and dose-finding of DTX301 with the same eligibility criteria, study arms, and outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%
Stay in the know with updates to DTX301 Clinical Trial in Late-Onset OTC Deficiency
Enter your email address, and we'll notify you when there's something new on the DTX301 Clinical Trial in Late-Onset OTC Deficiency page.